Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement in the Prevention of Lymphedema Following Locoregional Treatment for Breast Cancer (PREVENT)

NCT02167659 is registered in ClinicalTrials.gov with ImpediMed Limited as lead sponsor.

NCT NCT02167659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02167659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement in the Prevention of Lymphedema Following Locoregional Treatment for Breast Cancer (PREVENT)
Lead sponsor
ImpediMed Limited
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2014
Completion date
December 31, 2020
Enrollment
1,201 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

lymphedema